Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01869738 · ClinicalTrials.gov registry record · NA
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
A NA study, sponsored by InspireMD.
- Terminated
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT01869738 is a NA study that was terminated before completion, run by InspireMD. The registered enrollment target is 310 participants.
The verdict
NCT01869738, a NA study, was terminated before completion, sponsored by InspireMD.
- TERMINATED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of blocked arteries in coronary arteries in patients undergoing a stenting procedure due to having a heart attack. The MGuard Prime stent wil be compared to other FDA approved bare-metal (BMS) or drug-eluting (DES) coronary stents. The hypotheses are that (1) the MGuard Prime stent will achieve a higher rate of complete ST-segment resolution as seen on the post-procedure ECG as compared to the comparator stent, and will have a similar effect on the rate of all-cause death or recurrent target vessel myocardial infarction at 365 days post-procedure.
Interventions
- DEVICE MGuard Prime
- DEVICE (BMS/DES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01869738
The ClinicalTrials.gov registry entry for NCT01869738 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InspireMD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MGuard Prime is the first listed.
NCT01869738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01869738 about?
NCT01869738 is a clinical study titled "MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction". To evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of blocked arteries in coronary arteries in patients undergoing a stenting procedure due to having a heart attack. The MGuard Prime stent wil be compared to other FDA approved bare-metal (BMS) or drug-eluting (DES) coron...
What is the current status of trial NCT01869738?
This trial is currently terminated. It is a NA study. The enrollment target is 310 participants. The study started on 2013-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01869738?
The interventions under investigation include: MGuard Prime (DEVICE), (BMS/DES) (DEVICE).
Who is sponsoring clinical trial NCT01869738?
This trial is sponsored by InspireMD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.